ResMed Inc. (ResMed) develops, manufactures and distributes of medical equipment for treating, diagnosing, and managing sleep-disordered breathing and other respiratory disorders. Sleep-disordered breathing (SDB), includes obstructive sleep apnea (OSA), and other respiratory disorders that occur during sleep. It has developed a number of products for SDB and other respiratory disorders including airflow generators, diagnostic products, mask systems, headgear and other accessories. 

Company Growth (employees)
San Diego, US
Size (employees)
5,250 (est)+21%
ResMed was founded in 1989 and is headquartered in San Diego, US

ResMed Office Locations

ResMed has offices in San Diego, Kontich, Espoo, Moissy-Cramayel and in 24 other locations
San Diego, US (HQ)
9001 Spectrum Center Blvd
Rochester, US
1200 Brooks Ave
Singapore, SG
8 Loyang Cres
Hong Kong, HK
132 Nathan Rd
Guangzhou Shi, CN
Jian She Liu Ma Lu
Shanghai, CN
Wagas ( Shan Xi Bei Lu )
Show all (28)

ResMed Data and Metrics

ResMed Financial Metrics

ResMed's revenue was reported to be $1.8 b in FY, 2016 which is a 10% increase from the previous period.

Revenue (FY, 2016)

1.8 b

Revenue growth (FY, 2015 - FY, 2016), %


Gross profit (FY, 2016)

1.1 b

Gross profit margin (FY, 2016), %


Net income (FY, 2016)

352.4 m

EBIT (FY, 2016)

429 m

Market capitalization (21-Jul-2017)

11.1 b

Cash (30-Jun-2016)

731.4 m


11.3 b
ResMed's current market capitalization is $11.1 b.
USDFY, 2014FY, 2015FY, 2016


1.6 b1.7 b1.8 b

Revenue growth, %


Cost of goods sold

667.5 m772.2 m

Gross profit

1 b1.1 b

Gross profit Margin, %


R&D expense

118.7 m

General and administrative expense

488.1 m

Operating expense total

602.2 m637.5 m


409.2 m429 m

EBIT margin, %


Interest expense

5.8 m11.2 m

Interest income

26.2 m

Pre tax profit

435.9 m439.6 m

Income tax expense

83 m87.2 m

Net Income

345.3 m352.9 m352.4 m
USDFY, 2014FY, 2015FY, 2016


905.7 m717.2 m731.4 m


165.4 m246.9 m224.5 m

Current Assets

1.6 b1.4 b1.4 b


434.3 m387.8 m384.3 m


1.1 b

Total Assets

2.4 b2.2 b3.3 b

Accounts Payable

85.4 m81.1 m92.6 m

Total Debt

300.8 m300.6 m875 m

Current Liabilities

269.6 m267.3 m638.6 m

Non-Current Liabilities

333.2 m329.7 m925.6 m

Total Liabilities

602.7 m597 m1.6 b

Additional Paid-in Capital

1.1 b1.2 b1.3 b

Retained Earnings

1.8 b2 b2.2 b

Total Equity

1.8 b1.6 b1.7 b

Debt to Equity Ratio

0.2 x0.2 x0.5 x

Debt to Assets Ratio

0.1 x0.1 x0.3 x

Financial Leverage

1.3 x1.4 x1.9 x
USDFY, 2014FY, 2015FY, 2016

Net Income

345.3 m352.9 m352.4 m

Depreciation and Amortization

73.5 m73.1 m86.8 m

Accounts Receivable

(35 m)(28 m)(27.3 m)

Cash From Operating Activities

391.3 m383.2 m547.9 m

Purchases of PP&E

(72.7 m)(62.5 m)(58.5 m)

Cash From Investing Activities

(95 m)(143.1 m)(1.1 b)

Dividends Paid

(141.5 m)(157.3 m)(168.1 m)

Cash From Financing Activities

(297.3 m)(255.8 m)612.6 m

Interest Paid

6.1 m5.8 m11.2 m

Income Taxes Paid

90.2 m48.5 m69 m
USDY, 2016


26.2 x


20.5 x


423.7 k


0.5 x


0.3 x

Financial Leverage

1.9 x

ResMed Market Value History

ResMed Median Salaries

Source: 31 public H-1B filings from ResMed

ResMed Online and Social Media Presence

ResMed Company Life and Culture

You may also be interested in